Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2018MedicineOpen Access

Qishen Yiqi dripping pills will be evaluated for effectiveness and safety in a planned prospective cohort study of 1,200 patients with ischemic heart failure, with no results reported yet.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Does Qishen Yiqi dripping pills (QSYQ) added to standard western medicine improve NYHA classification and MLHFQ scores in patients with ischemic heart failure?

Population

1200 patients with ischemic heart failure (IHF) recruited from 84 hospitals in China

Comparison

Qishen Yiqi dripping pills plus standard western… vs Standard western medicine without QSYQ treatment

Design

Cohort

Follow-up

3 months

Key result

Qishen Yiqi dripping pills will be evaluated for effectiveness and safety in a planned prospective cohort study of 1,200 patients with ischemic heart failure, with no results reported yet.

Authors

ZZZhiqiang ZhaoXWXianliang WangYHYazhu Hou

Discussion

Loading...

Member takes

Overview

May support adjunctive QSYQ in real-world IHF but should not change practice; leaves open need for RCTs to confirm benefit.

Study Design

Type

Cohort (n=1,200)

Blinding

Outcome assessors and statisticians blinded

Multicenter

Yes

Structured PICO

Does Qishen Yiqi dripping pills (QSYQ) added to standard western medicine improve NYHA classification and MLHFQ scores in patients with ischemic heart failure?

P
Population
A planned prospective cohort study of 1,200 outpatients with ischemic heart failure (LVEF ≤ 50%, NYHA II-IV) to be followed for 3 months.
E
Exposure
Qishen Yiqi dripping pills (QSYQ) plus standard western medicine
C
Comparator
Standard western medicine without QSYQ treatment
O
Outcome
New York Heart Association (NYHA) cardiac functional classification and Minnesota Living with Heart Failure Questionnaire (MLHFQ)patient reported

Limitations

  • This is a study protocol, so no clinical results or conclusions are available yet.
  • Treatment assignment is based on patient preference, which may introduce confounding.

Cite This Study

Zhao et al. (2018) conducted a cohort in Ischemic heart failure (n=1,200). Qishen Yiqi dripping pills (QSYQ) vs. Standardized western medication without QSYQ was evaluated on New York Heart Association (NYHA) cardiac functional classification and Minnesota Living with Heart Failure Questionnaire (MLHFQ). Qishen Yiqi dripping pills will be evaluated for effectiveness and safety in a planned prospective cohort study of 1,200 patients with ischemic heart failure, with no results reported yet.

synapsesocial.com/papers/6a97d989883af1d6c8a683bchttps://doi.org/10.1097/md.0000000000013085
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and safety of Qishen Yiqi dripping pills as a complementary treatment for Heart Failure2021 · 3 citations
  2. 2Qishen Yiqi Dripping Pills for Chronic Ischaemic Heart Failure: Results of the CACT-IHF Randomized Clinical Trial2020 · 51 citations
  3. 3Effect of Qishen Yiqi dripping pills on the classification of ejection fraction in patients with ischaemic heart failure: A prospective cohort study2025 · 9 citations
  4. 4Effects of Qishen Yiqi dropping pills plus conventional Western medicine on cardiac function and quality of life of patients with chronic heart failure2026
  5. 5Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Coronary Heart Disease Complicating Chronic Heart Failure (Syndrome of Qi Deficiency with Blood Stasis): Study Protocol for a Randomized, Placebo-Controlled, Double-Blind and Multi-Centre Phase II Clinical Trial2023 · 11 citations